Citigroup Inc Sci Sparc Ltd. Transaction History

Citigroup Inc

  • $153 Billion
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
BUY
$1.89 - $3.68 $94 - $184
50 New
50 $0

Others Institutions Holding SPRC

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About SciSparc Ltd.

SPRC Quotes by TradingView
  • Ticker SPRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 3,526,740
  • Market Cap $917K
  • Description
  • SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum ...
More about SPRC
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email